Related Experiment Video
Updated: Jul 7, 2026

Murine Prostate Micro-dissection and Surgical Castration
Published on: May 11, 2016
Rad9 has a functional role in human prostate carcinogenesis
Aiping Zhu1, Charles Xia Zhang, Howard B Lieberman
1Center for Radiological Research, Columbia University, College of Physicians and Surgeons, New York, NY 10032, USA.
Abstract:
Prostate cancer is currently the most common type of neoplasm found in American men, other than skin cancer, and is the second leading cause of cancer death in males. Because cell cycle checkpoint proteins stabilize the genome, the relationship of one such protein, Rad9, to prostate cancer was investigated. We found that four prostate cancer cell lines (CWR22, DU145, LNCaP, and PC-3), relative to PrEC normal prostate cells, have aberrantly high levels of Rad9 protein. The 3'-end region of intron 2 of Rad9 in DU145 cells is hypermethylated at CpG islands, and treatment with 5'-aza-2'-deoxycytidine restores near-normal levels of methylation and reduces Rad9 protein abundance. Southern blot analyses indicate that PC-3 cells contain an amplified Rad9 copy number. Therefore, we provide evidence that Rad9 levels are high in prostate cancer cells due at least in part to aberrant methylation or gene amplification. The effectiveness of small interfering RNA to lower Rad9 protein levels in CWR22, DU145, and PC-3 cells correlated with reduction of tumorigenicity in nude mice, indicating that Rad9 actively contributes to the disease. Rad9 protein levels were high in 153 of 339 human prostate tumor biopsy samples examined and detectable in only 2 of 52 noncancerous prostate tissues. There was a strong correlation between Rad9 protein abundance and cancer stage. Rad9 protein level can thus provide a biomarker for advanced prostate cancer and is causally related to the disease, suggesting the potential for developing novel diagnostic, prognostic, and therapeutic tools based on detection or manipulation of Rad9 protein abundance.
Insights
Elevated Rad9 protein levels are common in prostate cancer, linked to aberrant methylation and gene amplification. Lowering Rad9 reduces tumor growth, suggesting its role as a biomarker and therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Prostate cancer is a leading cause of cancer death in men.
- Cell cycle checkpoint proteins, like Rad9, are crucial for genome stability.
- The role of Rad9 in prostate cancer pathogenesis requires investigation.
Purpose of the Study:
- To investigate the relationship between Rad9 protein levels and prostate cancer.
- To determine the mechanisms underlying elevated Rad9 expression in prostate cancer cells.
- To evaluate Rad9 as a potential biomarker and therapeutic target for prostate cancer.
Main Methods:
- Analysis of Rad9 protein levels in prostate cancer cell lines and human tumor samples.
- Investigation of DNA methylation patterns in Rad9 intron 2 using 5'-aza-2'-deoxycytidine treatment.
- Assessment of Rad9 gene copy number using Southern blot analysis.
- Evaluation of Rad9's functional role by small interfering RNA-mediated knockdown and tumorigenicity assays in nude mice.
Main Results:
- Four prostate cancer cell lines exhibited significantly higher Rad9 protein levels compared to normal prostate cells.
- Hypermethylation of Rad9 intron 2 in DU145 cells and gene amplification in PC-3 cells were identified as mechanisms for elevated Rad9.
- Rad9 knockdown reduced the tumorigenicity of prostate cancer cells in vivo.
- High Rad9 protein levels were detected in a majority of human prostate tumor samples, correlating with advanced cancer stage.
Conclusions:
- Aberrant DNA methylation and gene amplification contribute to elevated Rad9 protein levels in prostate cancer.
- Rad9 plays an active role in prostate cancer development and progression.
- Rad9 protein abundance serves as a promising biomarker for advanced prostate cancer and a potential target for novel diagnostic, prognostic, and therapeutic strategies.
Related Concept Videos
The Ras Gene
Ras is a superfamily...
Abnormal Proliferation
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:

